search
Back to results

MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy

Primary Purpose

Bowel Preparation Before Colonoscopy

Status
Recruiting
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
MoviPrep
Golytely
Sponsored by
Yale University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Bowel Preparation Before Colonoscopy focused on measuring colonoscopy, bowel preparation, inpatient, tolerability

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Provision of signed and dated informed consent form
  2. Stated willingness to comply with all study procedures and availability for the duration of the study
  3. Male or female, aged 18 or greater
  4. Hospitalized patient scheduled to undergo colonoscopy with bowel preparation (not including preparation with enemas alone)
  5. Ability to take bowel preparation and be willing to adhere to the regimen

Exclusion Criteria:

  1. Patients presenting to the hospital with ileus, toxic megacolon, evidence of gastrointestinal obstruction
  2. Receipt of bowel preparation for other reasons during their hospitalization prior to their colonoscopy
  3. Patients with prior significant gastrointestinal surgeries including colonic resection, subtotal colectomy, abdomino-perineal resection, Hartmann's procedure or other similar surgeries involving structure/function of small intestine or colon
  4. Unable to give informed consent to the procedure
  5. Known glucose-6-phosphate dehydrogenase deficiency
  6. Known phenylketonuria
  7. Known hypersensitivity to polyethylene glycols or ascorbic acid
  8. Patients undergoing colonoscopy for foreign body removal and/or decompression
  9. Pregnancy or lactating women

Sites / Locations

  • Bridgeport HospitalRecruiting
  • Yale New-Haven HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

MoviPrep

GoLYTELY

Arm Description

For MoviPrep, the dose, schedule, and route of administration are as follows: On the evening prior to the colonoscopy, mix the powder with lukewarm water to a total volume of 32 oz. Drink 8 oz. every 15 minutes until the solution is finished. Drink 16 oz. of clear liquids before bed. On the morning of the procedure, repeat the above steps and make sure all fluids are consumed at least 2 hours prior to colonoscopy. Limit food intake to a regular breakfast, light lunch and clear soup or plain yogurt for dinner on the day prior to the colonoscopy (completed at least 1 hour prior to the first MoviPrep dose. Consume only clear liquids from the start of MoviPrep until after the colonoscopy.

For GoLYTELY, the dose, schedule, and route of administrate are as follows: On the evening prior to the colonoscopy, mix powder with lukewarm water to a total volume of 4 liters. Drink 2 liters of the solution and store the rest in the refrigerator. Drink the remaining 2 liters on the morning of the procedure. Limit food intake to a light breakfast on the day prior to the colonoscopy, followed by only clear liquids until the procedure is complete. Avoid red and purple liquids.

Outcomes

Primary Outcome Measures

Boston Bowel Preparation Score (BBPS) During Colonoscopy Withdrawal
The BBPS is a validated scoring tool that assesses the three segments of the colon (left, transverse, right) and rates them from 1-3 based on the ability to visualize the mucosa. An adequate bowel preparation is defined as a BBPS of 6 or higher with no individual segment scoring less than a 2.

Secondary Outcome Measures

Mayo Clinic Bowel Preparation Questionnaire
The Mayo Clinic Bowel Preparation Questionnaire is a survey consisting of 9 questions that relate to symptoms and tolerability of bowel preparation before colonoscopy. The answers to each question will be aggregated for each arm and compared.
BBPS Score During Colonoscopy Withdrawal For Each Segment
BBPS assesses three segments of the colon (left, transverse, right) and rates each segment either a 1, 2, or 3 based on the ability to visualize the mucosa. Higher scores correspond to improved mucosal visibility.
Rates of "Excellent" Bowel Preparation
The BBPS is a validated scoring tool that assesses the three segments of the colon (left, transverse, right) and rates them from 1-3 based on the ability to visualize the mucosa. An excellent bowel preparation is defined as a BBPS score of an 8 or 9.
Cecal Intubation Rate
Percentage of colonoscopies during which the cecum is successfully reached
Cecal Intubation Time
Time from insertion of colonoscopy to reaching the cecum
Colonoscopy Withdrawal Time
Time from reaching the cecum to complete withdrawal of the colonoscope
Time to Endoscopy
The time from when the patient started the bowel preparation to the colonoscopy procedure itself.
Hospital Length of Stay
Time from admission to discharge
Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v5.0
The National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) is a descriptive terminology which can be utilized for Adverse Event (AE) reporting. A grading (severity) scale is provided for each AE term from a scale of 1-5, with increasing score corresponding to increasing AE severity.

Full Information

First Posted
September 9, 2021
Last Updated
July 11, 2023
Sponsor
Yale University
search

1. Study Identification

Unique Protocol Identification Number
NCT05054036
Brief Title
MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy
Official Title
Efficacy, Safety, and Tolerability of MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy: a Randomized Control Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 12, 2022 (Actual)
Primary Completion Date
January 1, 2024 (Anticipated)
Study Completion Date
March 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yale University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
Adequate bowel cleansing is a critical component in the care of hospitalized patients undergoing colonoscopy. However, inpatient status is a well-established risk factor for inadequate bowel preparation. However, few strategies have been rigorously shown to reduce the risk of inadequate bowel preparation. Moreover, inadequate bowel preparation is frequently related to the poor tolerability of high volumes of bowel preparation in the medically complex and comorbid hospitalized population. Low volume bowel preparations have been developed that have been shown to be noninferior compared to high volume bowel preparation with regards to adequacy of bowel preparation but with improved tolerability. However, the use of low volume bowel preparations for colonoscopies have largely been evaluated in the outpatient setting. In this study, we plan to compare rates of adequate bowel preparation and tolerability of a low volume bowel preparation, MoviPrep, compared to standard high volume bowel preparation, GoLYTELY, in hospitalized patients undergoing colonoscopy. This study promises to highlight low volume bowel preparation as a viable and better tolerated alternative to high volume bowel preparation in hospitalized patients which may ultimately decrease delays in inpatient endoscopy as well as hospital length of stay.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bowel Preparation Before Colonoscopy
Keywords
colonoscopy, bowel preparation, inpatient, tolerability

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
450 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
MoviPrep
Arm Type
Experimental
Arm Description
For MoviPrep, the dose, schedule, and route of administration are as follows: On the evening prior to the colonoscopy, mix the powder with lukewarm water to a total volume of 32 oz. Drink 8 oz. every 15 minutes until the solution is finished. Drink 16 oz. of clear liquids before bed. On the morning of the procedure, repeat the above steps and make sure all fluids are consumed at least 2 hours prior to colonoscopy. Limit food intake to a regular breakfast, light lunch and clear soup or plain yogurt for dinner on the day prior to the colonoscopy (completed at least 1 hour prior to the first MoviPrep dose. Consume only clear liquids from the start of MoviPrep until after the colonoscopy.
Arm Title
GoLYTELY
Arm Type
Active Comparator
Arm Description
For GoLYTELY, the dose, schedule, and route of administrate are as follows: On the evening prior to the colonoscopy, mix powder with lukewarm water to a total volume of 4 liters. Drink 2 liters of the solution and store the rest in the refrigerator. Drink the remaining 2 liters on the morning of the procedure. Limit food intake to a light breakfast on the day prior to the colonoscopy, followed by only clear liquids until the procedure is complete. Avoid red and purple liquids.
Intervention Type
Drug
Intervention Name(s)
MoviPrep
Intervention Description
Split-dose MoviPrep bowel preparation
Intervention Type
Drug
Intervention Name(s)
Golytely
Intervention Description
Split-dose GoLYTELY bowel preparation
Primary Outcome Measure Information:
Title
Boston Bowel Preparation Score (BBPS) During Colonoscopy Withdrawal
Description
The BBPS is a validated scoring tool that assesses the three segments of the colon (left, transverse, right) and rates them from 1-3 based on the ability to visualize the mucosa. An adequate bowel preparation is defined as a BBPS of 6 or higher with no individual segment scoring less than a 2.
Time Frame
At time of procedure, approximately 45 minutes
Secondary Outcome Measure Information:
Title
Mayo Clinic Bowel Preparation Questionnaire
Description
The Mayo Clinic Bowel Preparation Questionnaire is a survey consisting of 9 questions that relate to symptoms and tolerability of bowel preparation before colonoscopy. The answers to each question will be aggregated for each arm and compared.
Time Frame
Immediately prior to procedure
Title
BBPS Score During Colonoscopy Withdrawal For Each Segment
Description
BBPS assesses three segments of the colon (left, transverse, right) and rates each segment either a 1, 2, or 3 based on the ability to visualize the mucosa. Higher scores correspond to improved mucosal visibility.
Time Frame
At time of procedure, approximately 45 minutes
Title
Rates of "Excellent" Bowel Preparation
Description
The BBPS is a validated scoring tool that assesses the three segments of the colon (left, transverse, right) and rates them from 1-3 based on the ability to visualize the mucosa. An excellent bowel preparation is defined as a BBPS score of an 8 or 9.
Time Frame
At time of procedure, approximately 45 minutes
Title
Cecal Intubation Rate
Description
Percentage of colonoscopies during which the cecum is successfully reached
Time Frame
At time of procedure, approximately 45 minutes
Title
Cecal Intubation Time
Description
Time from insertion of colonoscopy to reaching the cecum
Time Frame
At time of procedure, approximately 45 minutes
Title
Colonoscopy Withdrawal Time
Description
Time from reaching the cecum to complete withdrawal of the colonoscope
Time Frame
At time of procedure, approximately 45 minutes
Title
Time to Endoscopy
Description
The time from when the patient started the bowel preparation to the colonoscopy procedure itself.
Time Frame
At time of procedure, approximately 45 minutes
Title
Hospital Length of Stay
Description
Time from admission to discharge
Time Frame
After study completion, an average of 5 days
Title
Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v5.0
Description
The National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) is a descriptive terminology which can be utilized for Adverse Event (AE) reporting. A grading (severity) scale is provided for each AE term from a scale of 1-5, with increasing score corresponding to increasing AE severity.
Time Frame
Through study completion, an average of 3 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Provision of signed and dated informed consent form Stated willingness to comply with all study procedures and availability for the duration of the study Male or female, aged 18 or greater Hospitalized patient scheduled to undergo colonoscopy with bowel preparation (not including preparation with enemas alone) Ability to take bowel preparation and be willing to adhere to the regimen Exclusion Criteria: Patients presenting to the hospital with ileus, toxic megacolon, evidence of gastrointestinal obstruction Receipt of bowel preparation for other reasons during their hospitalization prior to their colonoscopy Patients with prior significant gastrointestinal surgeries including colonic resection, subtotal colectomy, abdomino-perineal resection, Hartmann's procedure or other similar surgeries involving structure/function of small intestine or colon Unable to give informed consent to the procedure Known glucose-6-phosphate dehydrogenase deficiency Known phenylketonuria Known hypersensitivity to polyethylene glycols or ascorbic acid Patients undergoing colonoscopy for foreign body removal and/or decompression Pregnancy or lactating women
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Darrick K Li, MD, PhD
Phone
203-285-4506
Email
darrick.li@yale.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Darrick K Li, MD, PhD
Organizational Affiliation
Yale School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bridgeport Hospital
City
Bridgeport
State/Province
Connecticut
ZIP/Postal Code
06610
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Caroline Loeser, MD
Email
Caroline.Loeser@bpthosp.org
First Name & Middle Initial & Last Name & Degree
Valerie Assalone, BSN, RN
Phone
203-384-3193
Email
Valerie.Assalone@bpthosp.org
First Name & Middle Initial & Last Name & Degree
Caroline Loeser, MD
Facility Name
Yale New-Haven Hospital
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06510
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Darrick K Li, MD, PhD
Phone
203-285-4506
Email
darrick.li@yale.edu
First Name & Middle Initial & Last Name & Degree
Darrick K Li, MD, PhD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26093612
Citation
Yadlapati R, Johnston ER, Gregory DL, Ciolino JD, Cooper A, Keswani RN. Predictors of Inadequate Inpatient Colonoscopy Preparation and Its Association with Hospital Length of Stay and Costs. Dig Dis Sci. 2015 Nov;60(11):3482-90. doi: 10.1007/s10620-015-3761-2. Epub 2015 Jun 21.
Results Reference
background
PubMed Identifier
32200083
Citation
Fuccio L, Frazzoni L, Spada C, Mussetto A, Fabbri C, Manno M, Aragona G, Zagari RM, Rondonotti E, Manes G, Occhipinti P, Cadoni S, Bazzoli F, Hassan C, Radaelli F; QIPS study group. Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients. Clin Gastroenterol Hepatol. 2021 Feb;19(2):339-348.e7. doi: 10.1016/j.cgh.2020.02.055. Epub 2020 Mar 18.
Results Reference
background
PubMed Identifier
31683057
Citation
Spadaccini M, Frazzoni L, Vanella G, East J, Radaelli F, Spada C, Fuccio L, Benamouzig R, Bisschops R, Bretthauer M, Dekker E, Dinis-Ribeiro M, Ferlitsch M, Gralnek I, Jover R, Kaminski MF, Pellise M, Triantafyllou K, Van Hooft JE, Dumonceau JM, Marmo C, Alfieri S, Chandrasekar VT, Sharma P, Rex DK, Repici A, Hassan C. Efficacy and Tolerability of High- vs Low-Volume Split-Dose Bowel Cleansing Regimens for Colonoscopy: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2020 Jun;18(7):1454-1465.e14. doi: 10.1016/j.cgh.2019.10.044. Epub 2019 Nov 1.
Results Reference
background
PubMed Identifier
30986186
Citation
Garber A, Sarvepalli S, Burke CA, Bhatt A, Ibrahim M, McMichael J, Morris-Stiff G, Rizk MK, Vargo JJ, Rothberg MB. Modifiable Factors Associated with Quality of Bowel Preparation Among Hospitalized Patients Undergoing Colonoscopy. J Hosp Med. 2019 May;14(5):278-283. doi: 10.12788/jhm.3173.
Results Reference
background
PubMed Identifier
24953203
Citation
Patel M, Staggs E, Thomas CS, Lukens F, Wallace M, Almansa C. Development and validation of the Mayo Clinic Bowel Prep Tolerability Questionnaire. Dig Liver Dis. 2014 Sep;46(9):808-12. doi: 10.1016/j.dld.2014.05.020. Epub 2014 Jun 19.
Results Reference
background

Learn more about this trial

MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy

We'll reach out to this number within 24 hrs